Greener Peptide Synthesis: The Future of Fmoc-SPPS and Building Blocks

Fmoc solid-phase peptide synthesis has transformed peptide chemistry because it is reliable, modular and compatible with an enormous range of protected amino acid building blocks. Its weakness is equally well known: conventional SPPS can consume large quantities of solvent and reagents for repeated swelling, coupling, deprotection and washing cycles.

The sustainability discussion is therefore moving beyond a simple question of whether DMF should be replaced.

Recent work from 2024 to 2026 suggests that the next generation of peptide manufacturing will combine standard building blocks, greener solvents, lower solvent volumes, improved activation chemistry, alternative protecting groups and selective biocatalysis.

For researchers using Fmoc-protected amino acids, the important point is that this transition is unlikely to happen through one disruptive replacement technology. It is more likely to occur through several technologies that reduce the environmental burden of different steps.

Why Solvent Use Matters So Much

SPPS repeatedly exposes resin-bound peptides to solvent during coupling, deprotection and washing. This is one reason solvent dominates the material footprint of many peptide synthesis processes.

A frequently cited pharmaceutical manufacturing analysis estimated that solvents accounted for approximately 80–90% of the nonaqueous mass used in API manufacturing. Although this figure is not specific to every peptide process, it illustrates why solvent reduction has become such an important target for greener SPPS.

Recent peptide-specific studies show that meaningful reductions are possible.

The important observation is that these strategies attack different parts of the manufacturing problem rather than offering one universal replacement.

Figure 1. Recent quantitative advances in lower-impact peptide synthesis.
Recommended figure: separately show the reported 83–88% solvent reduction per coupling cycle in ultrasound-assisted SPPS and the greater-than-50% reduction in manufacturing steps reported for the 2026 biocatalytic enlicitide process. These metrics measure different process dimensions and should not be plotted as directly equivalent performance values.

The Near-Term Future Probably Still Uses Fmoc Amino Acids

A large amount of sustainable chemistry research focuses on replacing DMF, NMP and other problematic solvents while retaining standard Fmoc/tBu-protected amino acids.

That is not accidental.

Modern peptide laboratories already have a mature ecosystem of standard Fmoc amino acids, side-chain protecting groups, peptide synthesis resins and coupling reagents. Replacing this entire system creates significant technical and supply-chain barriers.

A 2024 study evaluated several alternative solvents for microwave-assisted SPPS and found N-butylpyrrolidinone suitable across five peptide examples, including difficult sequences such as ACP 65–74, Peptide 18A and thymosin α1.

More recent work has moved even further. A 2025 study demonstrated aqueous SPPS using standard Fmoc/tBu-protected amino acids, showing that greener synthesis does not necessarily require abandoning existing peptide building-block chemistry.

Alan Scientific View: in the near term, sustainable peptide synthesis is more likely to evolve around standard Fmoc building blocks than to replace them.

The installed base is simply too large, and the chemistry is too well understood. Improvements in solvent systems, wash volume, coupling efficiency and process control can therefore have greater immediate impact than introducing a completely new protection strategy.

Reducing Solvent Volume May Matter More Than Finding a Perfect Solvent

Much of green-chemistry development has focused on finding a direct replacement for DMF.

But a greener solvent used in very large quantities can still create a poor process.

A 2025 sustainable ultrasound-assisted SPPS study reported an 83–88% reduction in solvent consumption per coupling cycle.

This points to a broader principle.

The environmental footprint of SPPS depends not only on solvent identity, but also on how much solvent is required, how often resin must be washed, how efficiently amino acids couple and whether failed or incomplete reactions require repetition.

A process using fewer equivalents and fewer washes can sometimes be more important than a simple one-to-one solvent substitution.

This is particularly relevant for expensive peptide building blocks. Using four or five equivalents of a low-cost standard amino acid may be tolerable at research scale. The same strategy becomes much less attractive when a peptide contains costly D-amino acids, isotope-labeled residues or specialized noncanonical building blocks.

For complex peptides, sustainability and cost therefore begin to converge.

Reducing reagent excess can simultaneously reduce waste and protect the economics of synthesis.

Greener Manufacturing Is Becoming a Process Design Problem

A 2025 process study on octreotide illustrates the value of hybrid rather than absolute solutions.

Instead of eliminating DMF entirely, the investigators used γ-valerolactone for reaction steps while retaining DMF for washing, and also optimized cleavage and purification. The authors reported no adverse effect on cost, quality or yield relative to the conventional process.

This approach is noteworthy because it avoids an all-or-nothing definition of green chemistry.

A commercially useful peptide process has to satisfy several requirements at once:

chemical efficiency, product quality, impurity control, safety, supply availability and cost.

A solvent that looks attractive in an environmental guide may perform poorly if it does not swell a resin adequately, dissolve a protected amino acid or support efficient coupling.

Alan Scientific View: the most useful sustainability metric is not whether a process contains DMF. It is whether the complete process produces the required peptide with less hazardous material, lower total mass input and fewer repeated operations without compromising quality.

That is a more demanding standard, but it is also more relevant to real manufacturing.

New Protecting Groups Are Starting to Challenge Fmoc

Not every development is focused on improving conventional Fmoc chemistry.

In 2025, researchers reported Picoc-SPPS, a visible-light photocatalytic peptide synthesis strategy based on the hydrophilic Picoc protecting group. The system eliminates conventional piperidine deprotection and TFA-based chemistry in key operations, is compatible with water and γ-valerolactone, and allows recycling of an immobilized photocatalyst.

Scientifically, this is an important development.

Commercially, however, the challenge is larger.

Fmoc chemistry benefits from decades of accumulated infrastructure and a huge catalog of protected amino acids. A new protecting-group platform must eventually provide comparable coverage for:

standard residues, D-amino acids, orthogonally protected residues, noncanonical amino acids and specialized functional building blocks.

This is why a new deprotection chemistry can be scientifically convincing long before it becomes a mainstream manufacturing platform.

Figure 2. The emerging evolution of peptide synthesis chemistry.
Recommended schematic: conventional Fmoc/DMF SPPS, lower-volume SPPS, greener-solvent Fmoc-SPPS, aqueous Fmoc/tBu synthesis, alternative protecting-group chemistry and selective biocatalytic manufacturing. Label this figure as an Alan Scientific interpretation of current technology trends rather than experimental data.

Biocatalysis May Change How Complex Peptides Are Manufactured

The most forward-looking development may not be a new SPPS solvent at all.

In May 2026, Merck researchers reported a biocatalytic manufacturing route for the macrocyclic peptide enlicitide. Engineered enzymes were used for selective peptide fragment formation, coupling and macrocyclization in a protecting-group-free process. The new route reduced the number of steps by more than half compared with the previous state-of-the-art process, while crystallization replaced chromatography for major purification operations.

That result should not be interpreted as evidence that biocatalysis will replace SPPS for routine research peptides.

Enzyme development itself requires substantial investment and is most attractive when manufacturing scale justifies that effort.

But it reveals an important long-term trend.

The future of peptide manufacturing may become increasingly hybrid.

SPPS can remain highly efficient for certain fragments or discovery-scale molecules, while enzymes, solution-phase chemistry and crystallization can be introduced when they solve specific scale-up problems better.

For building-block suppliers, this may eventually broaden the market beyond conventional Fmoc amino acids toward tailored intermediates and substrates designed for enzymatic or convergent assembly.

Sustainability Will Increasingly Influence Building-Block Selection

Historically, peptide building blocks were selected primarily according to sequence, protecting-group compatibility and coupling efficiency.

Those criteria will remain essential, but manufacturing programs are increasingly likely to consider additional questions.

Can the amino acid dissolve efficiently in a lower-impact solvent? Does it require large reagent excess? Does its protecting group generate difficult waste? Can a more reactive or preorganized building block reduce repeated coupling? Can a pseudoproline or other aggregation-disrupting strategy prevent a failed synthesis cycle?

Alan Scientific's pseudoproline dipeptides provide a useful example of this broader thinking. They are normally selected to disrupt peptide aggregation and improve difficult synthesis. If that intervention reduces repeated couplings, failed batches or excessive reagent consumption, its value is not only synthetic—it also affects process efficiency.

This leads to a broader definition of a “green building block.”

It is not necessarily the molecule with the greenest-looking synthetic route in isolation.

It may be the building block that allows the complete peptide to be manufactured with fewer cycles, lower reagent excess and higher first-pass success.

Conclusion

Peptide synthesis is entering a period of rapid process innovation.

The immediate trend is toward reducing the environmental burden of conventional Fmoc-SPPS through greener solvent systems, lower solvent volume and more efficient reaction conditions. At the same time, aqueous Fmoc chemistry and alternative protecting groups are beginning to challenge assumptions about how peptide synthesis must be performed.

Beyond that, the 2026 biocatalytic manufacture of enlicitide shows that large-scale peptide production may increasingly combine chemistry, enzymes and crystallization rather than relying on one synthesis technology from beginning to end.

Alan Scientific View: Fmoc chemistry is unlikely to disappear soon. The more realistic transition is from a single standardized SPPS workflow toward a toolbox in which building block, solvent, resin, activation method and manufacturing technology are selected together.

For researchers, the practical objective remains unchanged: achieve the desired peptide with reliable identity and purity. The emerging difference is that efficiency, waste and manufacturability are becoming part of that optimization problem from the beginning.

Researchers planning custom peptide synthesis can also review Alan Scientific's guide to choosing Fmoc-protected amino acids, together with our portfolios of protected amino acids, resins and peptide coupling reagents.

References

1. Jad YE, et al. Green Solid-Phase Peptide Synthesis. ACS Sustainable Chemistry & Engineering.

2. Rasmussen JH, et al. N-Butylpyrrolidinone as an Alternative Solvent for Microwave-Assisted SPPS. Journal of Peptide Science. 2024.

3. Sustainable Ultrasound-Assisted Solid-Phase Peptide Synthesis: Less Waste, More Efficiency. 2025.

4. Aqueous Solid-Phase Peptide Synthesis Using Standard Fmoc/tBu-Protected Amino Acids. ACS Sustainable Chemistry & Engineering. 2025.

5. Optimized SPPS Process for Octreotide Using Green Solvent GVL. Organic Process Research & Development. 2025.

6. Sustainable Peptide Synthesis by Photoredox-Catalyzed Picoc-SPPS. Journal of the American Chemical Society. 2025.

7. Klapars A, et al. Biocatalytic Cascades Enable Manufacture of the Macrocyclic Peptide Enlicitide. Science. 2026.